Trial intelligence / Profile preview

Comparison of the Efficacy of Diclofenac Sodium Topical Gel 1% (Mylan) versus Voltaren Gel 1% and Placebo in Adult Subjects with Knee Osteoarthritis

2012-002682-36Phase 3Completed

Sponsor
Mylan
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diclofenac in knee osteoarthritis (OA) and osteoarthritis of peripheral joints (OA) (3 arms), sponsored by Mylan. Primary endpoint: WOMAC pain subscale. Started Jul 2012; status: completed.

02

Drugs

diclofenac
03

Conditions

knee osteoarthritis (OA)osteoarthritis of peripheral joints (OA)

Beyond the preview

Go deeper on 2012-002682-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002682-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call